Valneva SE VALN
NASDAQ VALN
$6.89 -0.17 (-2.40%)
As of: Sep 4, 2026 · 3:59 PM EDT

Valneva SE (VALN) Total Current Liabilities (2020 - 2026)

Valneva SE (VALN) posted Total Current Liabilities of $110.3 million for Q1 2026, up 1.53% sequentially from $108.6 million in Q4 2025, and down 1.26% YoY from $111.7 million in Q1 2025.

Analysis

Valneva SE (VALN) Total Current Liabilities (2020 - 2026) Analysis & Trends

Valneva SE has reported Total Current Liabilities for 7 years, with the latest figure at $110.3 million in Q1 2026.

  • Quarterly Total Current Liabilities fell 1.26% year-over-year to $110.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $110.3 million (down 1.26% YoY) and the FY2025 annual result came in at $108.6 million, down 12.39% from the prior year.
  • Total Current Liabilities advanced to $110.3 million in Q1 2026 per VALN's latest filing, from $108.6 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $465.4 million in Q2 2022 and troughed at $108.6 million in Q4 2025.
  • A 5-year average of $212.6 million and a median of $170.9 million in 2023 frame the typical range for Total Current Liabilities.
  • The sharpest annual moves came in 2024 and 2025: Total Current Liabilities plunged 57.95% in 2024, then surged 46.75% in 2025.
  • Over 5 years, Total Current Liabilities stood at $283.0 million in 2022, then sank by 39.6% to $170.9 million in 2023, then decreased by 28.37% to $122.4 million in 2024, then fell by 11.27% to $108.6 million in 2025, then rose by 1.53% to $110.3 million in 2026.
  • According to Business Quant data, Total Current Liabilities over the past three periods registered $110.3 million, $108.6 million, and $175.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 3.94 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 5.53 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.58 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 2.53 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 354.06 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 2.12 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 1.51 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 630.93 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 438.74 Mn
10 Valneva SE 578.54 Mn 437.28 Mn 1.86 Mn 120.11 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 120.11 Mn
Mar 31, 2026 110.31 Mn
Dec 31, 2025 108.64 Mn
Sep 30, 2025 175.92 Mn
Jun 30, 2025 142.24 Mn
Mar 31, 2025 111.71 Mn
Dec 31, 2024 122.44 Mn
Sep 30, 2024 119.88 Mn
Jun 30, 2024 110.37 Mn
Mar 31, 2024 126.11 Mn
Dec 31, 2023 170.93 Mn
Sep 30, 2023 237.48 Mn
Jun 30, 2023 262.48 Mn
Mar 31, 2023 282.57 Mn
Dec 31, 2022 283.01 Mn
Sep 30, 2022 377.31 Mn
Jun 30, 2022 465.37 Mn
Mar 31, 2022 407.70 Mn
Dec 31, 2021 422.10 Mn
Dec 31, 2020 209.69 Mn